| scholarly article | Q13442814 |
| P50 | author | Stanislas Goriely | Q39750759 |
| Cyril Gueydan | Q53850341 | ||
| Oberdan Leo | Q95947194 | ||
| P2093 | author name string | Perry J Blackshear | |
| Tong Zhang | |||
| Félicie Sherer | |||
| Gaetan Van Simaeys | |||
| Céline Molle | |||
| Mathieu Andrianne | |||
| Laure Ysebrant de Lendonck | |||
| P2860 | cites work | Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation | Q40362902 |
| Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes. | Q51834169 | ||
| Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability | Q73520889 | ||
| IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A | Q82966759 | ||
| Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses | Q83537393 | ||
| Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis | Q84078748 | ||
| Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. | Q22010036 | ||
| Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation | Q24316626 | ||
| Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay | Q28119130 | ||
| Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death | Q28199430 | ||
| Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover | Q28215400 | ||
| Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway | Q28350388 | ||
| Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells | Q28508125 | ||
| Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome | Q28510380 | ||
| A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency | Q28589649 | ||
| Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
| Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. | Q30436326 | ||
| The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
| Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation | Q34222410 | ||
| IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis | Q34577866 | ||
| Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence | Q35044265 | ||
| Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation | Q35685580 | ||
| Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype | Q35935919 | ||
| Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses | Q36294340 | ||
| Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma | Q36616576 | ||
| Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells | Q36699809 | ||
| Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation | Q36732543 | ||
| How microorganisms tip the balance between interleukin-12 family members | Q37033837 | ||
| Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation | Q37080841 | ||
| Post-transcriptional control of cytokine production | Q37113415 | ||
| Tristetraprolin mediates interferon-gamma mRNA decay | Q37160867 | ||
| Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction | Q37371456 | ||
| The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules | Q37415953 | ||
| IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. | Q37497970 | ||
| Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin | Q37557530 | ||
| Tristetraprolin down-regulates IL-17 through mRNA destabilization | Q39433745 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| interleukins | Q194908 | ||
| P304 | page(s) | 1675-1684 | |
| P577 | publication date | 2013-08-12 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease | |
| P478 | volume | 210 |
| Q33919012 | A balancing act: RNA binding protein HuR/TTP axis in endometriosis patients |
| Q39092491 | An Ancient Family of RNA-Binding Proteins: Still Important! |
| Q47329135 | Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway |
| Q52610481 | Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation. |
| Q98177695 | Context-Dependent IL-1 mRNA-Destabilization by TTP Prevents Dysregulation of Immune Homeostasis Under Steady State Conditions |
| Q58765534 | Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection |
| Q35208102 | Dysregulated serum IL-23 and SIRT1 activity in peripheral blood mononuclear cells of patients with rheumatoid arthritis |
| Q36811560 | Effects of Combined Tristetraprolin/Tumor Necrosis Factor Receptor Deficiency on the Splenic Transcriptome |
| Q94475250 | Effects of tristetraprolin on doxorubicin (adriamycin)-induced experimental kidney injury through inhibiting IL-13/STAT6 signal pathway |
| Q36607631 | Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies |
| Q42251092 | Gain-of-Function Mutation of Tristetraprolin Impairs Negative Feedback Control of Macrophages In Vitro yet Has Overwhelmingly Anti-Inflammatory Consequences In Vivo. |
| Q36014211 | Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment. |
| Q92760637 | IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response |
| Q90675719 | Interleukin 23 and autoimmune diseases: current and possible future therapies |
| Q39443989 | Limiting inflammation-the negative regulation of NF-κB and the NLRP3 inflammasome |
| Q47711556 | Non-genetic mechanisms of diabetic nephropathy |
| Q26747406 | Post-transcriptional Regulation of Immunological Responses through Riboclustering |
| Q38212815 | Post-transcriptional coordination of immunological responses by RNA-binding proteins. |
| Q39036700 | Post-transcriptional regulation of cytokine and growth factor signaling in cancer |
| Q26863295 | Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity |
| Q28507888 | RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence |
| Q27023916 | Regulation of AU-Rich Element RNA Binding Proteins by Phosphorylation and the Prolyl Isomerase Pin1 |
| Q38979324 | Regulation of Interleukin-23 Expression in Health and Disease |
| Q34456769 | Role of interleukin-22 in inflammatory bowel disease |
| Q89838042 | Slit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes |
| Q35573505 | Sustained interleukin-1β exposure modulates multiple steps in glucocorticoid receptor signaling, promoting split-resistance to the transactivation of prominent anti-inflammatory genes by glucocorticoids |
| Q90430023 | The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling |
| Q48114071 | The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome. |
| Q95936605 | The RNA-binding protein tristetraprolin regulates RALDH2 expression by intestinal dendritic cells and controls local Treg homeostasis |
| Q40212847 | The RNA-binding protein tristetraprolin schedules apoptosis of pathogen-engaged neutrophils during bacterial infection |
| Q47417882 | The role of RNA-binding protein tristetraprolin in cancer and immunity. |
| Q34044674 | The unfolded protein response and the phosphorylations of activating transcription factor 2 in the trans-activation of il23a promoter produced by β-glucans |
| Q38589466 | Translating the Untranslated Region. |
| Q35920823 | Tristetraprolin Limits Inflammatory Cytokine Production in Tumor-Associated Macrophages in an mRNA Decay-Independent Manner. |
| Q99404874 | Tristetraprolin Regulates TH17 Cell Function and Ameliorates DSS-Induced Colitis in Mice |
| Q38922458 | Tristetraprolin as a Therapeutic Target in Inflammatory Disease |
| Q33752343 | Tristetraprolin expression by keratinocytes controls local and systemic inflammation. |
| Q36561559 | Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway |
| Q41918691 | Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses |
| Q35106287 | Tristetraprolin mediates anti-inflammatory effect of carbon monoxide against DSS-induced colitis. |
| Q36184781 | Tristetraprolin regulation of interleukin-22 production |
Search more.